Specific Roles of Activin/Inhibin in Human Erythropoiesis in Vitro a
1991; Wiley; Volume: 628; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1991.tb17247.x
ISSN1749-6632
AutoresJohn Yu, L Maderazo, Li‐En Shao, Normand L. Frigon, Joan Vaughan, Wylie Vale, Alice L. Yu,
Tópico(s)Erythrocyte Function and Pathophysiology
ResumoAnnals of the New York Academy of SciencesVolume 628, Issue 1 p. 199-211 Specific Roles of Activin/Inhibin in Human Erythropoiesis in Vitroa JOHN YU, Corresponding Author JOHN YU Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037cAddress correspondence to John Yu, M.D., Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, California 92037.Search for more papers by this authorLINA MADERAZO, LINA MADERAZO Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037Search for more papers by this authorLI-EN SHAO, LI-EN SHAO Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037Search for more papers by this authorNORMAND L. FRIGON, NORMAND L. FRIGON Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037Search for more papers by this authorJOAN VAUGHAN, JOAN VAUGHAN Clayton Foundation Laboratories for Peptide Biology The Salk Institute for Biological Studies La Jolla, California 92037Search for more papers by this authorWYLIE VALE, WYLIE VALE Clayton Foundation Laboratories for Peptide Biology The Salk Institute for Biological Studies La Jolla, California 92037Search for more papers by this authorALICE YU, ALICE YU Department of Pediatrics University of California at San Diego La Jolla, California 92093Search for more papers by this author JOHN YU, Corresponding Author JOHN YU Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037cAddress correspondence to John Yu, M.D., Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, California 92037.Search for more papers by this authorLINA MADERAZO, LINA MADERAZO Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037Search for more papers by this authorLI-EN SHAO, LI-EN SHAO Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037Search for more papers by this authorNORMAND L. FRIGON, NORMAND L. FRIGON Department of Molecular and Experimental Medicine Research Institute of Scripps Clinic La Jolla, California 92037Search for more papers by this authorJOAN VAUGHAN, JOAN VAUGHAN Clayton Foundation Laboratories for Peptide Biology The Salk Institute for Biological Studies La Jolla, California 92037Search for more papers by this authorWYLIE VALE, WYLIE VALE Clayton Foundation Laboratories for Peptide Biology The Salk Institute for Biological Studies La Jolla, California 92037Search for more papers by this authorALICE YU, ALICE YU Department of Pediatrics University of California at San Diego La Jolla, California 92093Search for more papers by this author First published: July 1991 https://doi.org/10.1111/j.1749-6632.1991.tb17247.xCitations: 7 a This work was supported in part by Grant DK40218 from the National Institutes of Health. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Yu, J., L. Shao, V. Lemas, A. L. Yu, J. Vaughan, J. Rivier & W. Vale. 1987. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 330: 765– 767. 2 Rivier, J., J. Spiess, R. McClintock, J. Vaughan & W. Vale. 1985. Purification and partial characterization of inhibin from porcine follicular fluid. Biochem. Biophys. Res. Commun. 133: 120– 127. 3 Ling, N., S. Ying, N. Ueno, F. Esch, L. Denoroy & R. Guillemin. 1985. Isolation and partial characterization of a Mr, 32,000 protein with inhibin activity from porcine follicular fluid. Proc. Natl. Acad. Sci. USA 82: 7217– 7221. 4 Vale, W., J. Rivier, J. Vaughan, R. McClintock, A. Corrigan, W. Woo, D. Karr & J. Spiess. 1986. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776– 779. 5 Ling, N., F. Y. Ying, N. Ueno, F. Shimasaki, F. Esch, F. Hotta & R. Guittemin. 1986. Pituitary FSH is released by a heterodimer of the beta subunits from the two forms of inhibin. Nature 321: 779– 782. 6 Vale, W., A. Hsueh, C. Rivier & J. Yu. 1990. The inhibin/activin family of hormones and growth factors. Handb. Exp. Pharmacol. 95: 211– 248. 7 Mason, A. J., J. S. Hayflick, N. Ling, F. Esch, N. Ueno, S. Ying, R. Guillemin, H. Niall & P. H. Seeburg. 1985. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature 318: 659– 663. 8 Mayo, K. E., G. M. Cerelli, J. Spiess, J. Rivier, M. G. Rosenfeld, R. M. Evans & W. Vale. 1986. Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc. Natl. Acad. Sci. USA 83: 5849– 5853. 9 Derynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn & D. V. Goeddel. 1985. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701– 705. 10 Sporn, M. B., A. B. Roberts, L. M. Wakefield & R. K. Assoian. 1986. Transforming growth factor-beta biological function and chemical structure. Science 233: 532– 534. 11 Sporn, M. B., A. B. Roberts, L. M. Wakefield & B. Crombrugghe. 1987. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol. 105: 1039– 1045. 12 Cheifetz, S., J. A. Weatherbee, M. L. Tsang, J. K. Anderson, J. E. Mole, R. Lucas & J. Massague. 1987. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48: 409– 415. 13 Duke, P. T., P. Hansen, K. K. Iwata, C. Pieler & J. G. Foulkes. 1988. Identification of another member of the transforming growth factor type beta gene family. Proc. Natl. Acad. Sri. USA 85: 4715– 4719. 14 Metcalf, D., C. G. Begley, G. R. Johnson, N. A. Nicola, M. A. Vadas & A. F. Lopez. 1986. Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood 67: 37– 45. 15 Hutson, J. M., M. E. Fallat, S. Kamagata, P. K. Donahoe & G. P. Budzik. 1984. Phosphorylation events during Mullerian duct regression. Science 223: 586– 589. 16 Padgett, R. W., R. D. St. Johnston & W. M. Gelbart. 1987. A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor-beta family. Nature 325: 81– 84. 17 Tannahill, D., D. L. Weeks & D. A. Melton. 1988. A localized Xenopus maternal mRNA encodes a TGF-beta-like factor. J. Cell. Biochem. 12A: 182. 18 Smith, J. C., B. M. J. Price, K. Van Nimmen & D. Huylebroeck. 1990. Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature 345: 729– 734. 19 Singh, M. K. & J. Yu. 1984. Accumulation of a heat shock-like protein during differentiation of human erythroid cell line K562. Nature 309: 631– 633. 20 Vaughan, J. M., J. Rivier, A. Z. Corrigan, R. McClintock, C. A. Campen, D. Jolley, J. K. Vogelmayr, C. W. Bardin, C. Rivier & W. Vale. 1989. Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods Enzymol. 168: 588– 617. 21 Sawada, K., S. B. Krantz, J. S. Kans, E. N. Dessypris, S. Sawyer, A. D. Glick & C. I. Civin. 1987. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J. Clin. Invest. 80: 357– 366. 22 Iscove, N. N., F. Sieber & K. H. Winterhalter. 1974. Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J. Cell. Physiol. 83: 309– 320. 23 Chirgwin, J. J., A. E. Przybyla, R. J. MacDonald & W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294– 5299. 24 Glisia, V., R. Crkvenjakov & C. Byus. 1973. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13: 2633– 2637. 25 Wilson, J. T., L. B. Wilson, J. K. DeRiel, L. Villa-Komaroff, A. Efstratiadis, B. G. Forget & S. M. Weissman. 1978. Insertion of synthetic copies of human globin genes into bacterial plasmids. Nucleic Acids Res. 5: 563– 581. 26 Robb, J. A. 1983. Enzyme-immunolectin histological techniques for surgical pathology. Introducing “GAB”: A new glucose oxidase-avidin-biotin assay. In Clinical Laboratory Assays: New Technology and Future Direction. R. Nakamura & D. Tucker, Eds.: 323– 332. Masson Publishing, Inc. New York . 27 Yu, J., L.-E. Shao, J. Vaughan, W. Vale & A. L. Yu. 1989. Characterization of the potentiation effect of activin on human erythroid colony formation in vitro. Blood 73: 952– 960. 28 Gordon, M. Y., G. P. Riley, S. M. Watt & M. F. Greaves. 1987. Compartmentalization of a hematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326: 403– 405. 29 Burgess, A. W., E. M. A. Wilson & D. Metcalf. 1977. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood 49: 573– 583. 30 Campen, C. A. & W. Vale. 1988. Characterization of activin A binding sites on the human leukemia cell line K562. Biochem. Biophys. Res. Commun. 157: 844– 849. 31 Charnay, P. & T. Maniatis. 1983. Transcriptional regulation of globin gene expression in the human erythroid cell line K562. Science 220: 1281– 1283. 32 Ley, T. J., K. A. Maloney, J. I. Gordon & A. L. Schwartz. 1989. Globin gene expression in erythroid human fetal liver cells. J. Clin. Invest. 83: 1032– 1038. 33 Yu, J., N. L. Frigon, Jr., L. Shao & A. Yu. 1990. Regulation of human erythropoiesis in vitro by activin. Blood. (Abstr.) 76: 173a. 34 Clark, S. C. & R. Kamen. 1987. The human hematopoietic colony-stimulating factors. Science 236: 1229– 1237. 35 Roberts, R., J. Gallagher, E. Spooncer, T. B. Allen, F. Bloomfield & T. M. Dexter. 1988. Heparan sulphate bound growth factors: A mechanism for stromal cell mediated hemopoiesis. Nature 332: 376– 378. 36 Murata, M., Y. Eto, H. Shibai, M. Sakai & M. Muramatsu. 1988. Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain. Proc. Natl. Acad. Sci. USA 85: 2434– 2438. 37 Meunier, H., C. Rivier, R. M. Evans & W. Vale. 1988. Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc. Natl. Acad. Sci. USA 85: 247– 251. Citing Literature Volume628, Issue1Negative Regulators of Hematopoiesis: Studies on Their Nature, Action, and Potential Role in Cancer TherapyJuly 1991Pages 199-211 ReferencesRelatedInformation
Referência(s)